Interestingly, n-3 PUFAs supplementation in the form of capsules (2g n-3 PUFAs per day/3 months) significantly decreased IL-6 and TNFα levels in patients with chronic heart failure [37], and CRP and IL-6 levels were significantly decreased in overweight women with an inflammatory phenotype [38]. Here, IL6 is linked to congestive heart failure.